Research library

Selected reports, profiles and newsletters, in one place.

WallStreet Research has published hundreds of reports over five decades, distributed to over 200,000 investor subscribers worldwide. These are the reports and profiles featured online, covering emerging growth companies on NASDAQ, NYSE, AMEX, OTC Markets, TSX, CSE and global exchanges.

47Featured online
8Market groups
1998 to 2026Years of coverage
Skinvisible, Inc. logo

Skinvisible, Inc.

OTCQB: SKVIPharmaceuticals and drug delivery

Research Report, 12 pages

Develops topical and transdermal products made with its patented skin delivery system, Invisicare®, and filed a provisional patent for a transdermal obesity medication delivery method.

Borqs Technologies, Inc. logo

Borqs Technologies, Inc.

OTCQB: BRQSFInternet of Things

Updated Research Report, 11 pages

A global leader in embedded software and products for the Internet of Things, offering Android based smart connected devices, 5G and end to end cloud services.

Cytta Corp. logo

Cytta Corp.

OTCQB: CYCAVideo streaming technology

Initial Research Report, 7 pages

Develops proprietary technology that changes how video is streamed, consumed, transferred and stored, including advanced video compression and portable hardware systems.

HeartCore Enterprises, Inc. logo

HeartCore Enterprises, Inc.

NASDAQ: HTCREnterprise software

Initial Research Report, 8 pages

A Tokyo based software development company offering SaaS products globally, plus data analytics that help enterprises create tailored web experiences.

ClearOne, Inc. logo

ClearOne, Inc.

NASDAQ: CLROCommunications technology

Updated Research Report, 12 pages

Designs, develops and sells conferencing, collaboration and network streaming solutions for voice and visual communications.

Elys Game Technology, Corp. logo

Elys Game Technology, Corp.

NASDAQ: ELYSGaming technology

Updated Research Report, 15 pages

Formerly Newgioco Group, Inc. An international technology firm providing betting platforms for leisure gaming operators in Europe and the U.S., from lottery and casino gaming to sports betting.

Halo Labs, Inc. logo

Halo Labs, Inc.

OTCQX: AGEEF, NEO: HALOCannabis

Updated Research Report, 12 pages

A global cannabis cultivation, extraction, distribution and branded product company with expertise across all major cannabis manufacturing processes.

NuLoch Resources Inc. logo

NuLoch Resources Inc.

TSXV: NLR, OTCQX: NULCFOil and gas

Analyst Report, 14 pages

A Calgary-based oil and gas company focused on the Bakken Shale and Three Forks Sanish formations of the Williston Basin. It holds over 66,000 net acres in North Dakota and Saskatchewan, and its production reached about 1,100 barrels of oil equivalent per day in late 2010.

Acquired by Magnum Hunter for $400 million

USA Technologies, Inc.

NASDAQ: USATCashless payment technology

Analyst Report, 10 pages

Supplies networked devices for wireless cashless payment in vending machines, laundry equipment, kiosks and more, along with energy management products. It has strategic relationships with MasterCard, Coca-Cola Enterprises, AT&T and First Data.

Nymox Pharmaceutical Corporation

NASDAQ: NYMXPharmaceuticals

Updated Research Report

A biopharmaceutical company in New Jersey and Montreal developing therapeutic and diagnostic products for the aging population. It completed Phase II trials of its NX-1207 drug candidate for enlarged prostate and sells AlzheimAlert, a urine test that aids the diagnosis of Alzheimer's disease.

Brainstorm Cell Therapeutics, Inc. logo

Brainstorm Cell Therapeutics, Inc.

OTC BB: BCLICell therapy

Initial Research Report

A development-stage biotechnology company developing adult stem cell therapies for neurodegenerative diseases such as Parkinson's, ALS and multiple sclerosis. Its NurOwn technology, licensed from Tel Aviv University, turns a patient's own bone marrow stem cells into neural-like cells.

Uplisted to NASDAQ: BCLI
Questcor Pharmaceuticals, Inc. logo

Questcor Pharmaceuticals, Inc.

AMEX: QSCPharmaceuticals

Research Report

A specialty pharmaceutical company in Hayward, California, serving the acute care and critical care hospital markets. Formed in 1999 through the merger of RiboGene and Cypros Pharmaceutical, it markets four acute care products and has critical care drugs in clinical development.

Acquired by Mallinckrodt plc for $5.8 billion

WallStreet Research provides research services to publicly traded companies on a fee basis, the nature and amount of which is fully disclosed in each report. Read the Disclaimer